| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of chromatin | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.13e-18 | 100 | 57 | 13 | GO:0030527 |
| GeneOntologyMolecularFunction | protein heterodimerization activity | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 SOHLH2 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TENM2 H2BC12 H2BC18 | 2.47e-13 | 398 | 57 | 15 | GO:0046982 |
| GeneOntologyMolecularFunction | structural molecule activity | H2BC12L SPTBN4 H2BC11 NID2 TUBB3 H2BC13 H2BC15 H2BC14 MXRA5 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.46e-10 | 891 | 57 | 17 | GO:0005198 |
| GeneOntologyMolecularFunction | protein dimerization activity | H2BC12L H2BC11 RASIP1 DPP4 H2BC13 H2BC15 H2BC14 H2BC9 SOHLH2 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 TENM2 H2BC12 H2BC18 | 2.33e-08 | 1205 | 57 | 17 | GO:0046983 |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 3.59e-04 | 118 | 57 | 4 | GO:0003774 | |
| GeneOntologyMolecularFunction | STAT family protein binding | 6.12e-04 | 13 | 57 | 2 | GO:0097677 | |
| GeneOntologyBiologicalProcess | nucleosome assembly | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NAP1L3 H2BC3 | 5.67e-13 | 122 | 53 | 10 | GO:0006334 |
| GeneOntologyBiologicalProcess | nucleosome organization | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NAP1L3 H2BC3 | 2.63e-12 | 142 | 53 | 10 | GO:0034728 |
| GeneOntologyBiologicalProcess | innate immune response in mucosa | 1.22e-10 | 30 | 53 | 6 | GO:0002227 | |
| GeneOntologyBiologicalProcess | protein-DNA complex assembly | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NAP1L3 H2BC3 | 6.79e-10 | 249 | 53 | 10 | GO:0065004 |
| GeneOntologyBiologicalProcess | mucosal immune response | 2.43e-09 | 48 | 53 | 6 | GO:0002385 | |
| GeneOntologyBiologicalProcess | organ or tissue specific immune response | 5.05e-09 | 54 | 53 | 6 | GO:0002251 | |
| GeneOntologyBiologicalProcess | antibacterial humoral response | 8.05e-08 | 85 | 53 | 6 | GO:0019731 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral immune response mediated by antimicrobial peptide | 1.20e-06 | 134 | 53 | 6 | GO:0061844 | |
| GeneOntologyBiologicalProcess | defense response to Gram-positive bacterium | 2.32e-06 | 150 | 53 | 6 | GO:0050830 | |
| GeneOntologyBiologicalProcess | antimicrobial humoral response | 8.01e-06 | 186 | 53 | 6 | GO:0019730 | |
| GeneOntologyBiologicalProcess | chromatin remodeling | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NAP1L3 H2BC3 | 1.62e-05 | 741 | 53 | 10 | GO:0006338 |
| GeneOntologyBiologicalProcess | chromatin organization | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NAP1L3 H2BC3 | 8.11e-05 | 896 | 53 | 10 | GO:0006325 |
| GeneOntologyBiologicalProcess | humoral immune response | 1.68e-04 | 321 | 53 | 6 | GO:0006959 | |
| GeneOntologyBiologicalProcess | protein-DNA complex organization | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 NAP1L3 H2BC3 | 1.98e-04 | 999 | 53 | 10 | GO:0071824 |
| GeneOntologyBiologicalProcess | defense response to bacterium | 5.81e-04 | 405 | 53 | 6 | GO:0042742 | |
| GeneOntologyCellularComponent | nucleosome | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.77e-17 | 138 | 56 | 13 | GO:0000786 |
| GeneOntologyCellularComponent | chromatin | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 SOHLH2 H2BC4 H2BC17 H2BC21 NAP1L3 H2BC5 H2BC3 H2BC12 H2BC18 | 5.35e-06 | 1480 | 56 | 15 | GO:0000785 |
| Domain | H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.29e-26 | 21 | 56 | 12 | SM00427 |
| Domain | HISTONE_H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.29e-26 | 21 | 56 | 12 | PS00357 |
| Domain | Histone_H2B | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.29e-26 | 21 | 56 | 12 | IPR000558 |
| Domain | Histone | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.56e-20 | 56 | 56 | 12 | PF00125 |
| Domain | Histone_H2A/H2B/H3 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.56e-20 | 56 | 56 | 12 | IPR007125 |
| Domain | Histone-fold | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.24e-17 | 83 | 56 | 12 | IPR009072 |
| Domain | - | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 9.91e-17 | 69 | 56 | 11 | 1.10.20.10 |
| Domain | YD | 8.78e-05 | 5 | 56 | 2 | IPR006530 | |
| Domain | VPS9 | 2.44e-04 | 8 | 56 | 2 | SM00167 | |
| Domain | VPS9 | 3.91e-04 | 10 | 56 | 2 | PS51205 | |
| Domain | VPS9 | 3.91e-04 | 10 | 56 | 2 | PF02204 | |
| Domain | VPS9 | 3.91e-04 | 10 | 56 | 2 | IPR003123 | |
| Domain | Quino_amine_DH_bsu | 1.96e-03 | 22 | 56 | 2 | IPR011044 | |
| Domain | RA | 3.88e-03 | 31 | 56 | 2 | SM00314 | |
| Domain | RA | 5.50e-03 | 37 | 56 | 2 | PS50200 | |
| Domain | Myosin_head_motor_dom | 5.79e-03 | 38 | 56 | 2 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 5.79e-03 | 38 | 56 | 2 | PS51456 | |
| Domain | Myosin_head | 5.79e-03 | 38 | 56 | 2 | PF00063 | |
| Domain | MYSc | 5.79e-03 | 38 | 56 | 2 | SM00242 | |
| Domain | - | 6.09e-03 | 39 | 56 | 2 | 2.120.10.30 | |
| Domain | RA_dom | 6.40e-03 | 40 | 56 | 2 | IPR000159 | |
| Pathway | REACTOME_REPLACEMENT_OF_PROTAMINES_BY_NUCLEOSOMES_IN_THE_MALE_PRONUCLEUS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.21e-21 | 42 | 47 | 12 | M48029 |
| Pathway | REACTOME_RECOGNITION_AND_ASSOCIATION_OF_DNA_GLYCOSYLASE_WITH_SITE_CONTAINING_AN_AFFECTED_PURINE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.62e-19 | 55 | 47 | 12 | M29526 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.86e-19 | 62 | 47 | 12 | M27700 |
| Pathway | REACTOME_DNA_METHYLATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.19e-18 | 64 | 47 | 12 | M27429 |
| Pathway | REACTOME_RNA_POLYMERASE_I_PROMOTER_ESCAPE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 ERCC3 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.40e-18 | 90 | 47 | 13 | M27691 |
| Pathway | REACTOME_ACTIVATED_PKN1_STIMULATES_TRANSCRIPTION_OF_AR_ANDROGEN_RECEPTOR_REGULATED_GENES_KLK2_AND_KLK3 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.78e-18 | 66 | 47 | 12 | M27488 |
| Pathway | REACTOME_SIRT1_NEGATIVELY_REGULATES_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.16e-18 | 67 | 47 | 12 | M27342 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.16e-18 | 67 | 47 | 12 | M39003 |
| Pathway | REACTOME_ASSEMBLY_OF_THE_ORC_COMPLEX_AT_THE_ORIGIN_OF_REPLICATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.61e-18 | 68 | 47 | 12 | M27658 |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.61e-18 | 68 | 47 | 12 | M27587 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_THE_HUMAN_SILENCING_HUB_HUSH_COMPLEX | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.80e-18 | 70 | 47 | 12 | M48261 |
| Pathway | REACTOME_CHROMATIN_MODIFICATIONS_DURING_THE_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.80e-18 | 70 | 47 | 12 | M48028 |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.46e-18 | 72 | 47 | 12 | M29714 |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.46e-18 | 72 | 47 | 12 | M27132 |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.52e-18 | 73 | 47 | 12 | M27166 |
| Pathway | REACTOME_ERCC6_CSB_AND_EHMT2_G9A_POSITIVELY_REGULATE_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.23e-18 | 75 | 47 | 12 | M27343 |
| Pathway | REACTOME_MEIOTIC_SYNAPSIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.52e-17 | 78 | 47 | 12 | M1061 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.52e-17 | 78 | 47 | 12 | M27589 |
| Pathway | REACTOME_NEGATIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 ERCC3 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.69e-17 | 108 | 47 | 13 | M27426 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.79e-17 | 79 | 47 | 12 | M27191 |
| Pathway | REACTOME_RNA_POLYMERASE_I_TRANSCRIPTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 ERCC3 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.16e-17 | 110 | 47 | 13 | M27696 |
| Pathway | REACTOME_MEIOTIC_RECOMBINATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.04e-17 | 88 | 47 | 12 | M1011 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_OF_GRANULOPOIESIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.12e-17 | 89 | 47 | 12 | M27943 |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.35e-17 | 90 | 47 | 12 | M2158 |
| Pathway | REACTOME_B_WICH_COMPLEX_POSITIVELY_REGULATES_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.35e-17 | 90 | 47 | 12 | M29668 |
| Pathway | REACTOME_FORMATION_OF_THE_BETA_CATENIN_TCF_TRANSACTIVATING_COMPLEX | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.07e-16 | 91 | 47 | 12 | M27101 |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_PKNS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.41e-16 | 93 | 47 | 12 | M27487 |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.61e-16 | 94 | 47 | 12 | M1080 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.61e-16 | 94 | 47 | 12 | M27230 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.10e-16 | 96 | 47 | 12 | M27792 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_PIWI_INTERACTING_RNAS_PIRNAS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.39e-16 | 97 | 47 | 12 | M48262 |
| Pathway | REACTOME_PROCESSING_OF_DNA_DOUBLE_STRAND_BREAK_ENDS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.39e-16 | 97 | 47 | 12 | M27590 |
| Pathway | REACTOME_HCMV_EARLY_EVENTS | H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.52e-16 | 138 | 47 | 13 | M29805 |
| Pathway | REACTOME_DISEASES_OF_PROGRAMMED_CELL_DEATH | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.71e-16 | 104 | 47 | 12 | M29829 |
| Pathway | REACTOME_POSITIVE_EPIGENETIC_REGULATION_OF_RRNA_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.43e-16 | 105 | 47 | 12 | M27425 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.24e-16 | 106 | 47 | 12 | M27458 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS_BY_KRAB_ZFP_PROTEINS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.13e-16 | 107 | 47 | 12 | M48260 |
| Pathway | REACTOME_AMYLOID_FIBER_FORMATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.15e-15 | 110 | 47 | 12 | M27958 |
| Pathway | REACTOME_SENESCENCE_ASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.28e-15 | 111 | 47 | 12 | M27187 |
| Pathway | WP_SENESCENCEASSOCIATED_SECRETORY_PHENOTYPE_SASP | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.43e-15 | 112 | 47 | 12 | M48334 |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.43e-15 | 112 | 47 | 12 | M4052 |
| Pathway | REACTOME_HCMV_LATE_EVENTS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.21e-15 | 116 | 47 | 12 | M29806 |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.03e-15 | 119 | 47 | 12 | M607 |
| Pathway | REACTOME_MEIOSIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.36e-15 | 120 | 47 | 12 | M529 |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 3.40e-15 | 59 | 47 | 10 | M27763 |
| Pathway | REACTOME_HCMV_INFECTION | H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.76e-15 | 162 | 47 | 13 | M29804 |
| Pathway | REACTOME_ACTIVATION_OF_ANTERIOR_HOX_GENES_IN_HINDBRAIN_DEVELOPMENT_DURING_EARLY_EMBRYOGENESIS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.11e-15 | 122 | 47 | 12 | M29689 |
| Pathway | REACTOME_OXIDATIVE_STRESS_INDUCED_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.54e-15 | 125 | 47 | 12 | M27186 |
| Pathway | REACTOME_MATERNAL_TO_ZYGOTIC_TRANSITION_MZT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.42e-15 | 128 | 47 | 12 | M48019 |
| Pathway | REACTOME_RUNX1_REGULATES_TRANSCRIPTION_OF_GENES_INVOLVED_IN_DIFFERENTIATION_OF_HSCS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 8.16e-15 | 129 | 47 | 12 | M27795 |
| Pathway | KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.03e-14 | 139 | 47 | 12 | M4741 |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.03e-14 | 139 | 47 | 12 | M715 |
| Pathway | REACTOME_CHROMOSOME_MAINTENANCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.03e-14 | 139 | 47 | 12 | M868 |
| Pathway | REACTOME_HOMOLOGY_DIRECTED_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.22e-14 | 140 | 47 | 12 | M27584 |
| Pathway | REACTOME_MITOTIC_PROPHASE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.63e-14 | 142 | 47 | 12 | M27660 |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.63e-14 | 142 | 47 | 12 | M48257 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.63e-14 | 142 | 47 | 12 | M27233 |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.72e-14 | 149 | 47 | 12 | M27888 |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 7.43e-14 | 79 | 47 | 10 | M27742 |
| Pathway | REACTOME_REPRODUCTION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.60e-14 | 158 | 47 | 12 | M26956 |
| Pathway | REACTOME_DNA_REPLICATION_PRE_INITIATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.04e-13 | 159 | 47 | 12 | M27665 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.87e-13 | 167 | 47 | 12 | M19381 |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.32e-13 | 170 | 47 | 12 | M27582 |
| Pathway | REACTOME_DNA_REPLICATION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 7.26e-13 | 187 | 47 | 12 | M1017 |
| Pathway | REACTOME_EPIGENETIC_REGULATION_OF_GENE_EXPRESSION | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 ERCC3 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.27e-12 | 254 | 47 | 13 | M27131 |
| Pathway | REACTOME_CELLULAR_SENESCENCE | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.35e-12 | 197 | 47 | 12 | M27188 |
| Pathway | REACTOME_HATS_ACETYLATE_HISTONES | 1.94e-12 | 46 | 47 | 8 | MM14935 | |
| Pathway | REACTOME_ESR_MEDIATED_SIGNALING | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 4.99e-12 | 220 | 47 | 12 | M27794 |
| Pathway | REACTOME_UB_SPECIFIC_PROCESSING_PROTEASES | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.27e-12 | 221 | 47 | 12 | M27578 |
| Pathway | REACTOME_HDACS_DEACETYLATE_HISTONES | 8.83e-12 | 55 | 47 | 8 | MM14932 | |
| Pathway | REACTOME_TCF_DEPENDENT_SIGNALING_IN_RESPONSE_TO_WNT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 9.82e-12 | 233 | 47 | 12 | M27099 |
| Pathway | REACTOME_DEUBIQUITINATION | H2BC11 OTUB2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.00e-11 | 299 | 47 | 13 | M27574 |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_RUNX1 | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.20e-11 | 237 | 47 | 12 | M27786 |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.86e-11 | 246 | 47 | 12 | M10189 |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | H2BC12L H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.63e-11 | 323 | 47 | 13 | M27080 |
| Pathway | REACTOME_DNA_REPAIR | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 ERCC3 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 3.71e-11 | 332 | 47 | 13 | M15434 |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.99e-11 | 272 | 47 | 12 | M29619 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.31e-10 | 291 | 47 | 12 | M16647 |
| Pathway | REACTOME_SIGNALING_BY_NUCLEAR_RECEPTORS | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.59e-10 | 296 | 47 | 12 | M27869 |
| Pathway | REACTOME_SIGNALING_BY_WNT | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 5.56e-10 | 330 | 47 | 12 | M7847 |
| Pathway | REACTOME_M_PHASE | H2BC12L H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.22e-10 | 417 | 47 | 13 | M27662 |
| Pathway | REACTOME_INHIBITION_OF_DNA_RECOMBINATION_AT_TELOMERE | 6.82e-10 | 31 | 47 | 6 | MM17225 | |
| Pathway | REACTOME_CONDENSATION_OF_PROPHASE_CHROMOSOMES | 2.12e-09 | 37 | 47 | 6 | MM14883 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR_AP_SITE_FORMATION | 2.51e-09 | 38 | 47 | 6 | MM15434 | |
| Pathway | REACTOME_PRC2_METHYLATES_HISTONES_AND_DNA | 2.96e-09 | 39 | 47 | 6 | MM14850 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | H2BC12L DOCK5 H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ZAP70 H2BC12 | 5.91e-09 | 720 | 47 | 15 | M41838 |
| Pathway | REACTOME_RUNX1_REGULATES_GENES_INVOLVED_IN_MEGAKARYOCYTE_DIFFERENTIATION_AND_PLATELET_FUNCTION | 6.33e-09 | 44 | 47 | 6 | MM15527 | |
| Pathway | REACTOME_E3_UBIQUITIN_LIGASES_UBIQUITINATE_TARGET_PROTEINS | 7.29e-09 | 45 | 47 | 6 | MM15508 | |
| Pathway | REACTOME_NONHOMOLOGOUS_END_JOINING_NHEJ | 9.56e-09 | 47 | 47 | 6 | MM15296 | |
| Pathway | REACTOME_DEPOSITION_OF_NEW_CENPA_CONTAINING_NUCLEOSOMES_AT_THE_CENTROMERE | 1.40e-08 | 50 | 47 | 6 | MM15308 | |
| Pathway | REACTOME_CELL_CYCLE_MITOTIC | H2BC12L H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.22e-08 | 561 | 47 | 13 | M5336 |
| Pathway | REACTOME_DNA_DAMAGE_TELOMERE_STRESS_INDUCED_SENESCENCE | 2.26e-08 | 54 | 47 | 6 | MM14904 | |
| Pathway | REACTOME_REGULATION_OF_ENDOGENOUS_RETROELEMENTS | 2.83e-08 | 56 | 47 | 6 | MM17236 | |
| Pathway | REACTOME_DNA_DOUBLE_STRAND_BREAK_RESPONSE | 3.15e-08 | 57 | 47 | 6 | MM15298 | |
| Pathway | REACTOME_ESTROGEN_DEPENDENT_GENE_EXPRESSION | 5.81e-08 | 63 | 47 | 6 | MM15613 | |
| Pathway | REACTOME_PROTEIN_UBIQUITINATION | 7.03e-08 | 65 | 47 | 6 | MM15490 | |
| Pathway | REACTOME_BASE_EXCISION_REPAIR | 8.45e-08 | 67 | 47 | 6 | MM15429 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 1.00e-07 | 175 | 47 | 8 | MM14941 | |
| Pathway | REACTOME_G2_M_DNA_DAMAGE_CHECKPOINT | 1.31e-07 | 72 | 47 | 6 | MM15381 | |
| Pathway | REACTOME_TELOMERE_MAINTENANCE | 1.54e-07 | 74 | 47 | 6 | MM14605 | |
| Pubmed | Inhibition of core histones acetylation by carcinogenic nickel(II). | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.00e-30 | 18 | 57 | 12 | 16283522 |
| Pubmed | Apoptotic phosphorylation of histone H2B is mediated by mammalian sterile twenty kinase. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.00e-30 | 18 | 57 | 12 | 12757711 |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.93e-29 | 22 | 57 | 12 | 16713563 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.45e-28 | 23 | 57 | 12 | 16307923 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 9.17e-27 | 30 | 57 | 12 | 16319397 | |
| Pubmed | Quantitative proteomic analysis of post-translational modifications of human histones. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 | 1.06e-21 | 17 | 57 | 9 | 16627869 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.68e-21 | 77 | 57 | 12 | 12408966 | |
| Pubmed | 5.12e-21 | 11 | 57 | 8 | 15197225 | ||
| Pubmed | Histone modifications associated with somatic hypermutation. | 5.12e-21 | 11 | 57 | 8 | 16039583 | |
| Pubmed | Enhancement of the p300 HAT activity by HIV-1 Tat on chromatin DNA. | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.39e-19 | 69 | 57 | 11 | 11689053 |
| Pubmed | Histone H2B as a functionally important plasminogen receptor on macrophages. | 1.99e-19 | 15 | 57 | 8 | 17690254 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.70e-19 | 73 | 57 | 11 | 14657027 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 2.70e-19 | 73 | 57 | 11 | 9566873 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 1.83e-18 | 86 | 57 | 11 | 11080476 | |
| Pubmed | Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants. | H2BC12L H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.56e-18 | 256 | 57 | 14 | 35777956 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC12 | 1.40e-17 | 67 | 57 | 10 | 25253489 | |
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 H2BC18 | 1.68e-17 | 277 | 57 | 14 | 30745168 | |
| Pubmed | 2.64e-16 | 55 | 57 | 9 | 9439656 | ||
| Pubmed | H2BC12L H2BC11 TUBB3 OTUB2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.41e-16 | 438 | 57 | 15 | 21630459 | |
| Pubmed | Substrate and functional diversity of lysine acetylation revealed by a proteomics survey. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.33e-16 | 203 | 57 | 12 | 16916647 |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.03e-14 | 271 | 57 | 12 | 32433965 |
| Pubmed | TUBB3 H2BC13 H2BC15 H2BC14 ERCC3 H2BC9 H2BC4 H2BC21 H2BC5 H2BC3 H2BC18 | 3.50e-14 | 206 | 57 | 11 | 22174317 | |
| Pubmed | H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 4.80e-14 | 212 | 57 | 11 | 23463506 | |
| Pubmed | Gene-specific characterization of human histone H2B by electron capture dissociation. | 5.92e-14 | 6 | 57 | 5 | 16457587 | |
| Pubmed | Regulation of error-prone translesion synthesis by Spartan/C1orf124. | 6.48e-14 | 59 | 57 | 8 | 23254330 | |
| Pubmed | H2BC12L H2BC11 TUBB3 MYO3A H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 2.88e-13 | 844 | 57 | 16 | 25963833 | |
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 7.31e-13 | 477 | 57 | 13 | 31300519 |
| Pubmed | Molecular Characterization of the Oncogene BTF3 and Its Targets in Colorectal Cancer. | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ZAP70 H2BC12 H2BC18 | 1.23e-12 | 626 | 57 | 14 | 33644029 |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.09e-12 | 425 | 57 | 12 | 21081503 | |
| Pubmed | 1.96e-11 | 14 | 57 | 5 | 10064132 | ||
| Pubmed | Endotoxin-neutralizing antimicrobial proteins of the human placenta. | 3.24e-11 | 5 | 57 | 4 | 11859126 | |
| Pubmed | Biochemical and antibacterial analysis of human wound and blister fluid. | 3.24e-11 | 5 | 57 | 4 | 8620898 | |
| Pubmed | Antimicrobial peptides in the first line defence of human colon mucosa. | 8.33e-11 | 18 | 57 | 5 | 12860195 | |
| Pubmed | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.67e-10 | 451 | 57 | 11 | 36168627 | |
| Pubmed | 2.26e-10 | 7 | 57 | 4 | 15019208 | ||
| Pubmed | 2.66e-10 | 247 | 57 | 9 | 30713523 | ||
| Pubmed | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 1.36e-09 | 878 | 57 | 13 | 37223481 | |
| Pubmed | H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 3.64e-09 | 1153 | 57 | 14 | 29845934 | |
| Pubmed | 7.22e-09 | 88 | 57 | 6 | 26318153 | ||
| Pubmed | Autoimmunity to isomerized histone H2B in systemic lupus erythematosus. | 8.32e-08 | 6 | 57 | 3 | 22967069 | |
| Pubmed | Characterization of the 55-kb mouse histone gene cluster on chromosome 3. | 1.45e-07 | 7 | 57 | 3 | 8858345 | |
| Pubmed | The activity-dependent histone variant H2BE modulates the life span of olfactory neurons. | 1.45e-07 | 7 | 57 | 3 | 23240083 | |
| Pubmed | 2.32e-07 | 8 | 57 | 3 | 9710638 | ||
| Pubmed | Human histone gene organization: nonregular arrangement within a large cluster. | 3.27e-07 | 35 | 57 | 4 | 9119399 | |
| Pubmed | 7.40e-07 | 622 | 57 | 9 | 14574404 | ||
| Pubmed | 1.18e-06 | 13 | 57 | 3 | 8858344 | ||
| Pubmed | 2.64e-06 | 2 | 57 | 2 | 8611618 | ||
| Pubmed | SPTBN4 H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.09e-06 | 1442 | 57 | 12 | 35575683 | |
| Pubmed | 3.79e-06 | 565 | 57 | 8 | 20458337 | ||
| Pubmed | 3.97e-06 | 19 | 57 | 3 | 16522924 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 3562244 | ||
| Pubmed | 7.91e-06 | 3 | 57 | 2 | 9582374 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | 9.12e-06 | 847 | 57 | 9 | 35235311 | |
| Pubmed | 1.54e-05 | 491 | 57 | 7 | 22623428 | ||
| Pubmed | Interactome study suggests multiple cellular functions of hepatoma-derived growth factor (HDGF). | 1.57e-05 | 191 | 57 | 5 | 21907836 | |
| Pubmed | A novel divergently transcribed human histone H2A/H2B gene pair. | 1.58e-05 | 4 | 57 | 2 | 1768865 | |
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 11929833 | ||
| Pubmed | 1.58e-05 | 4 | 57 | 2 | 26974126 | ||
| Pubmed | Global regulation of post-translational modifications on core histones. | 1.58e-05 | 4 | 57 | 2 | 11709551 | |
| Pubmed | Cloning and characterization of the histone-fold proteins YBL1 and YCL1. | 1.58e-05 | 4 | 57 | 2 | 11000277 | |
| Pubmed | 2.21e-05 | 205 | 57 | 5 | 27976729 | ||
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | H2BC12L TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 H2BC12 H2BC18 | 2.34e-05 | 954 | 57 | 9 | 36373674 |
| Pubmed | 2.63e-05 | 5 | 57 | 2 | 35074526 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | H2BC12L TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 TMEM70 H2BC5 H2BC12 H2BC18 | 3.37e-05 | 1257 | 57 | 10 | 37317656 |
| Pubmed | 3.94e-05 | 6 | 57 | 2 | 12686141 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | 4.53e-05 | 394 | 57 | 6 | 27248496 | |
| Pubmed | 5.51e-05 | 7 | 57 | 2 | 27122172 | ||
| Pubmed | 5.69e-05 | 250 | 57 | 5 | 33536335 | ||
| Pubmed | 6.37e-05 | 419 | 57 | 6 | 15635413 | ||
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 18635963 | ||
| Pubmed | Arginylation-dependent neural crest cell migration is essential for mouse development. | 7.34e-05 | 8 | 57 | 2 | 20300656 | |
| Pubmed | 7.34e-05 | 8 | 57 | 2 | 8647104 | ||
| Pubmed | 9.24e-05 | 652 | 57 | 7 | 31180492 | ||
| Pubmed | The genomic organization of the histone clusters on human 6p21.3. | 9.43e-05 | 9 | 57 | 2 | 10384058 | |
| Pubmed | 9.43e-05 | 9 | 57 | 2 | 26479788 | ||
| Pubmed | Loss of nidogen-1 and -2 results in syndactyly and changes in limb development. | 1.44e-04 | 11 | 57 | 2 | 17023412 | |
| Pubmed | 1.44e-04 | 11 | 57 | 2 | 21084308 | ||
| Pubmed | Local generation of fumarate promotes DNA repair through inhibition of histone H3 demethylation. | 1.44e-04 | 11 | 57 | 2 | 26237645 | |
| Pubmed | 1.74e-04 | 169 | 57 | 4 | 23665500 | ||
| Pubmed | 1.78e-04 | 170 | 57 | 4 | 36470425 | ||
| Pubmed | An 'equalized cDNA library' by the reassociation of short double-stranded cDNAs. | 2.03e-04 | 13 | 57 | 2 | 2216762 | |
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 29285303 | ||
| Pubmed | Basement membranes in skin are differently affected by lack of nidogen 1 and 2. | 2.03e-04 | 13 | 57 | 2 | 18356808 | |
| Pubmed | 2.03e-04 | 13 | 57 | 2 | 18796539 | ||
| Pubmed | Isolation and characterization of two human H1 histone genes within clusters of core histone genes. | 2.03e-04 | 13 | 57 | 2 | 1916825 | |
| Pubmed | EMILIN1-α4/α9 integrin interaction inhibits dermal fibroblast and keratinocyte proliferation. | 2.37e-04 | 14 | 57 | 2 | 21949412 | |
| Pubmed | 3.12e-04 | 16 | 57 | 2 | 25416818 | ||
| Pubmed | Poly(ADP-ribosyl)ation directs recruitment and activation of an ATP-dependent chromatin remodeler. | 3.12e-04 | 16 | 57 | 2 | 19666485 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | 3.19e-04 | 564 | 57 | 6 | 21565611 | |
| Pubmed | Circular rapid amplification of cDNA ends for high-throughput extension cloning of partial genes. | 3.62e-04 | 84 | 57 | 3 | 15203218 | |
| Pubmed | A 1.1-Mb transcript map of the hereditary hemochromatosis locus. | 3.97e-04 | 18 | 57 | 2 | 9149941 | |
| Pubmed | 3.97e-04 | 18 | 57 | 2 | 19410543 | ||
| Pubmed | Organization of focal adhesion plaques is disrupted by action of the HIV-1 protease. | 3.97e-04 | 18 | 57 | 2 | 12119179 | |
| Pubmed | Four novel Loci (19q13, 6q24, 12q24, and 5q14) influence the microcirculation in vivo. | 4.43e-04 | 19 | 57 | 2 | 21060863 | |
| Pubmed | 4.43e-04 | 19 | 57 | 2 | 23329831 | ||
| Pubmed | 4.43e-04 | 19 | 57 | 2 | 27671872 | ||
| Pubmed | Np95 is a histone-binding protein endowed with ubiquitin ligase activity. | 4.92e-04 | 20 | 57 | 2 | 14993289 | |
| Pubmed | Circular RNA profile in liver tissue of EpCAM knockout mice. | 5.97e-04 | 22 | 57 | 2 | 31524221 | |
| Pubmed | 9.75e-04 | 267 | 57 | 4 | 33417871 | ||
| Pubmed | 1.04e-03 | 29 | 57 | 2 | 18077674 | ||
| Interaction | CDK5R2 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.53e-23 | 23 | 56 | 11 | int:CDK5R2 |
| Interaction | TNN interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.53e-23 | 23 | 56 | 11 | int:TNN |
| Interaction | CYLC1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.12e-21 | 20 | 56 | 10 | int:CYLC1 |
| Interaction | HMGN3 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.77e-19 | 64 | 56 | 12 | int:HMGN3 |
| Interaction | DUOX2 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.38e-19 | 30 | 56 | 10 | int:DUOX2 |
| Interaction | TEX35 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.49e-18 | 57 | 56 | 11 | int:TEX35 |
| Interaction | HMGN4 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 ATE1 H2BC12 H2BC18 | 5.26e-17 | 100 | 56 | 12 | int:HMGN4 |
| Interaction | H2BC11 interactions | H2BC11 RIN3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SPANXN2 H2BC5 H2BC3 H2BC12 H2BC18 | 8.21e-17 | 186 | 56 | 14 | int:H2BC11 |
| Interaction | H2BC15 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 SPANXN2 H2BC5 H2BC3 H2BC12 H2BC18 | 1.06e-16 | 144 | 56 | 13 | int:H2BC15 |
| Interaction | H2AC7 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.22e-16 | 107 | 56 | 12 | int:H2AC7 |
| Interaction | H2AC25 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.28e-16 | 84 | 56 | 11 | int:H2AC25 |
| Interaction | DPPA2 interactions | H2BC11 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.29e-15 | 40 | 56 | 9 | int:DPPA2 |
| Interaction | FAM47B interactions | 1.47e-15 | 13 | 56 | 7 | int:FAM47B | |
| Interaction | LOC102724334 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.97e-15 | 134 | 56 | 12 | int:LOC102724334 |
| Interaction | H2BC14 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.16e-15 | 100 | 56 | 11 | int:H2BC14 |
| Interaction | ZNF474 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 3.31e-15 | 44 | 56 | 9 | int:ZNF474 |
| Interaction | H2BC17 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.36e-15 | 140 | 56 | 12 | int:H2BC17 |
| Interaction | HCLS1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.77e-15 | 71 | 56 | 10 | int:HCLS1 |
| Interaction | H2AC12 interactions | H2BC11 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 H2BC18 | 2.06e-14 | 118 | 56 | 11 | int:H2AC12 |
| Interaction | HMGN2 interactions | H2BC11 H2BC13 H2BC15 H2BC14 MXRA5 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.08e-14 | 222 | 56 | 13 | int:HMGN2 |
| Interaction | H2BC18 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.06e-14 | 180 | 56 | 12 | int:H2BC18 |
| Interaction | H2BC26 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 8.62e-14 | 183 | 56 | 12 | int:H2BC26 |
| Interaction | H2AC6 interactions | H2BC11 H2BC13 H2BC15 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.68e-13 | 100 | 56 | 10 | int:H2AC6 |
| Interaction | H2AC18 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 2.58e-13 | 148 | 56 | 11 | int:H2AC18 |
| Interaction | PCLO interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC12 H2BC18 | 2.87e-13 | 70 | 56 | 9 | int:PCLO |
| Interaction | JPH2 interactions | 4.01e-13 | 25 | 56 | 7 | int:JPH2 | |
| Interaction | H2BC13 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 4.46e-13 | 210 | 56 | 12 | int:H2BC13 |
| Interaction | H2AC13 interactions | H2BC11 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.49e-13 | 75 | 56 | 9 | int:H2AC13 |
| Interaction | H2BC1 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.97e-12 | 178 | 56 | 11 | int:H2BC1 |
| Interaction | SFMBT2 interactions | 2.77e-12 | 32 | 56 | 7 | int:SFMBT2 | |
| Interaction | H2BC12 interactions | H2BC11 DPP4 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.54e-12 | 322 | 56 | 13 | int:H2BC12 |
| Interaction | ICAM1 interactions | H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 DNASE1L1 H2BC12 H2BC18 | 3.86e-12 | 252 | 56 | 12 | int:ICAM1 |
| Interaction | MCM5 interactions | H2BC12L H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.15e-12 | 420 | 56 | 14 | int:MCM5 |
| Interaction | H2AC14 interactions | H2BC11 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.80e-12 | 144 | 56 | 10 | int:H2AC14 |
| Interaction | H2AC1 interactions | 1.96e-11 | 71 | 56 | 8 | int:H2AC1 | |
| Interaction | H2BC21 interactions | H2BC11 RIN3 H2BC13 H2BC15 H2BC14 SFRP4 H2BC9 H2BC4 H2BC17 H2BC21 SPANXN2 H2BC5 H2BC3 DNAH5 H2BC12 H2BC18 | 3.97e-11 | 696 | 56 | 16 | int:H2BC21 |
| Interaction | PDS5B interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.62e-11 | 178 | 56 | 10 | int:PDS5B |
| Interaction | H2BC3 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 6.41e-11 | 406 | 56 | 13 | int:H2BC3 |
| Interaction | H2AJ interactions | H2BC11 H2BC13 H2BC15 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.94e-11 | 127 | 56 | 9 | int:H2AJ |
| Interaction | H2AC11 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.18e-11 | 248 | 56 | 11 | int:H2AC11 |
| Interaction | H2BC5 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 9.23e-11 | 331 | 56 | 12 | int:H2BC5 |
| Interaction | H2BC4 interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.14e-10 | 259 | 56 | 11 | int:H2BC4 |
| Interaction | PSMD14 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 H2BC18 | 1.25e-10 | 527 | 56 | 14 | int:PSMD14 |
| Interaction | UBA52 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 H2BC18 | 1.59e-10 | 437 | 56 | 13 | int:UBA52 |
| Interaction | MAP1B interactions | H2BC12L H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.68e-10 | 539 | 56 | 14 | int:MAP1B |
| Interaction | H2BC9 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 H2BC18 | 2.04e-10 | 446 | 56 | 13 | int:H2BC9 |
| Interaction | TOMM70 interactions | 3.69e-10 | 153 | 56 | 9 | int:TOMM70 | |
| Interaction | CD81 interactions | H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 6.04e-10 | 303 | 56 | 11 | int:CD81 |
| Interaction | H2AC4 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 DNAH5 H2BC12 H2BC18 | 9.54e-10 | 506 | 56 | 13 | int:H2AC4 |
| Interaction | IGSF8 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 1.01e-09 | 239 | 56 | 10 | int:IGSF8 |
| Interaction | PDCD4 interactions | 1.28e-09 | 176 | 56 | 9 | int:PDCD4 | |
| Interaction | RPS27A interactions | H2BC11 RIN3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.91e-09 | 536 | 56 | 13 | int:RPS27A |
| Interaction | TMEM196 interactions | 3.71e-09 | 8 | 56 | 4 | int:TMEM196 | |
| Interaction | ELK4 interactions | 6.33e-09 | 92 | 56 | 7 | int:ELK4 | |
| Interaction | H2AX interactions | H2BC11 RIN3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.44e-09 | 593 | 56 | 13 | int:H2AX |
| Interaction | ADARB1 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 7.72e-09 | 489 | 56 | 12 | int:ADARB1 |
| Interaction | ADAMTS12 interactions | 9.12e-09 | 55 | 56 | 6 | int:ADAMTS12 | |
| Interaction | HMGA1 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.77e-08 | 419 | 56 | 11 | int:HMGA1 |
| Interaction | MCM2 interactions | H2BC12L H2BC11 TUBB3 MYO3A H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 2.30e-08 | 1081 | 56 | 16 | int:MCM2 |
| Interaction | BTF3 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 ZAP70 H2BC12 H2BC18 | 2.61e-08 | 799 | 56 | 14 | int:BTF3 |
| Interaction | PINK1 interactions | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 3.20e-08 | 679 | 56 | 13 | int:PINK1 |
| Interaction | DOK2 interactions | 3.20e-08 | 116 | 56 | 7 | int:DOK2 | |
| Interaction | RIOK1 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 3.59e-08 | 562 | 56 | 12 | int:RIOK1 |
| Interaction | UBB interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.35e-08 | 467 | 56 | 11 | int:UBB |
| Interaction | MEPCE interactions | H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 6.43e-08 | 859 | 56 | 14 | int:MEPCE |
| Interaction | H2AZ1 interactions | H2BC11 H2BC13 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 6.64e-08 | 371 | 56 | 10 | int:H2AZ1 |
| Interaction | ARHGAP24 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 8.01e-08 | 486 | 56 | 11 | int:ARHGAP24 |
| Interaction | MAPK7 interactions | 1.36e-07 | 143 | 56 | 7 | int:MAPK7 | |
| Interaction | HEXIM1 interactions | H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 1.36e-07 | 913 | 56 | 14 | int:HEXIM1 |
| Interaction | TOP2A interactions | H2BC11 H2BC13 H2BC15 H2BC9 H2BC17 H2BC21 SPANXN2 H2BC5 SRP68 H2BC12 H2BC18 | 1.58e-07 | 520 | 56 | 11 | int:TOP2A |
| Interaction | TMA7 interactions | 1.73e-07 | 46 | 56 | 5 | int:TMA7 | |
| Interaction | H2AC20 interactions | 2.26e-07 | 320 | 56 | 9 | int:H2AC20 | |
| Interaction | LARP7 interactions | H2BC11 TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DIABLO H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 2.36e-07 | 1113 | 56 | 15 | int:LARP7 |
| Interaction | USF3 interactions | 2.51e-07 | 20 | 56 | 4 | int:USF3 | |
| Interaction | H2AC21 interactions | 2.58e-07 | 234 | 56 | 8 | int:H2AC21 | |
| Interaction | IPO9 interactions | 2.75e-07 | 236 | 56 | 8 | int:IPO9 | |
| Interaction | H3-4 interactions | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 H2BC5 DNAH5 H2BC12 | 3.80e-07 | 448 | 56 | 10 | int:H3-4 |
| Interaction | H2AZ2 interactions | 4.06e-07 | 168 | 56 | 7 | int:H2AZ2 | |
| Interaction | HMGN1 interactions | 4.06e-07 | 168 | 56 | 7 | int:HMGN1 | |
| Interaction | PRKCB interactions | 4.95e-07 | 255 | 56 | 8 | int:PRKCB | |
| Interaction | EIF1AX interactions | 7.03e-07 | 113 | 56 | 6 | int:EIF1AX | |
| Interaction | H3-5 interactions | 7.40e-07 | 114 | 56 | 6 | int:H3-5 | |
| Interaction | KNOP1 interactions | 8.06e-07 | 272 | 56 | 8 | int:KNOP1 | |
| Interaction | TIMM44 interactions | 1.00e-06 | 280 | 56 | 8 | int:TIMM44 | |
| Interaction | HNRNPD interactions | RASIP1 TUBB3 RIN3 H2BC13 H2BC15 H2BC9 H2BC4 H2BC5 H2BC3 ITGB4 H2BC12 | 1.20e-06 | 638 | 56 | 11 | int:HNRNPD |
| Interaction | MAP7D2 interactions | 1.46e-06 | 70 | 56 | 5 | int:MAP7D2 | |
| Interaction | TTN interactions | 1.64e-06 | 299 | 56 | 8 | int:TTN | |
| Interaction | H3C15 interactions | 1.65e-06 | 207 | 56 | 7 | int:H3C15 | |
| Interaction | SECISBP2L interactions | 2.33e-06 | 34 | 56 | 4 | int:SECISBP2L | |
| Interaction | H4C7 interactions | 2.63e-06 | 35 | 56 | 4 | int:H4C7 | |
| Interaction | MAGIX interactions | 2.63e-06 | 35 | 56 | 4 | int:MAGIX | |
| Interaction | SPON2 interactions | 3.30e-06 | 11 | 56 | 3 | int:SPON2 | |
| Interaction | ATAD5 interactions | 3.61e-06 | 84 | 56 | 5 | int:ATAD5 | |
| Interaction | CC2D1B interactions | 3.68e-06 | 38 | 56 | 4 | int:CC2D1B | |
| Interaction | SPRTN interactions | H2BC12L TUBB3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC5 H2BC3 H2BC12 H2BC18 | 4.96e-06 | 596 | 56 | 10 | int:SPRTN |
| Interaction | H3C1 interactions | H2BC11 DPP4 H2BC13 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 5.37e-06 | 901 | 56 | 12 | int:H3C1 |
| Interaction | SERBP1 interactions | H2BC12L H2BC11 OTUB2 RIN3 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 SRP68 H2BC3 H2BC12 H2BC18 | 5.58e-06 | 1432 | 56 | 15 | int:SERBP1 |
| Interaction | TNRC18 interactions | 5.65e-06 | 92 | 56 | 5 | int:TNRC18 | |
| Interaction | OSBPL9 interactions | 6.96e-06 | 96 | 56 | 5 | int:OSBPL9 | |
| Interaction | C11orf58 interactions | 8.92e-06 | 101 | 56 | 5 | int:C11orf58 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr6p22 | H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC5 H2BC3 H2BC12 | 3.89e-11 | 378 | 57 | 10 | chr6p22 |
| Cytoband | 6p22.1 | 2.51e-08 | 142 | 57 | 6 | 6p22.1 | |
| Cytoband | 14q32.12 | 6.02e-04 | 29 | 57 | 2 | 14q32.12 | |
| Cytoband | 1q21.2 | 3.56e-03 | 71 | 57 | 2 | 1q21.2 | |
| Cytoband | 6p21.3 | 3.76e-03 | 250 | 57 | 3 | 6p21.3 | |
| GeneFamily | Histones | H2BC12L H2BC11 H2BC13 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 H2BC18 | 1.63e-19 | 116 | 40 | 13 | 864 |
| GeneFamily | VPS9 domain containing | 2.12e-04 | 10 | 40 | 2 | 928 | |
| Coexpression | GSE41176_WT_VS_TAK1_KO_ANTI_IGM_STIM_BCELL_24H_DN | 4.07e-10 | 200 | 56 | 9 | M9952 | |
| Coexpression | NUYTTEN_NIPP1_TARGETS_UP | H2BC12L H2BC11 NID2 H2BC13 H2BC15 H2BC14 H2BC9 H2BC17 H2BC21 H2BC5 H2BC3 H2BC12 | 6.29e-08 | 768 | 56 | 12 | M6444 |
| Coexpression | HASLINGER_B_CLL_WITH_6Q21_DELETION | 1.33e-07 | 22 | 56 | 4 | M7362 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.38e-07 | 111 | 56 | 6 | MM705 | |
| Coexpression | GSE43260_BTLA_POS_VS_NEG_INTRATUMORAL_CD8_TCELL_DN | 2.21e-07 | 199 | 56 | 7 | M9954 | |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_UP | 1.95e-06 | 96 | 56 | 5 | M1683 | |
| Coexpression | ZENG_GU_ICB_CONTROL_METAGENE_14_PRECICTIVE_ICB_RESPONSE | 4.08e-06 | 198 | 56 | 6 | MM17083 | |
| Coexpression | ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN | 7.87e-06 | 222 | 56 | 6 | M16955 | |
| Coexpression | MARSON_BOUND_BY_E2F4_UNSTIMULATED | 1.89e-05 | 714 | 56 | 9 | M1744 | |
| Coexpression | BENPORATH_MYC_MAX_TARGETS | H2BC12L H2BC11 H2BC15 H2BC14 H2BC9 H2BC4 H2BC21 DIABLO SRP68 | 3.60e-05 | 775 | 56 | 9 | M17753 |
| Coexpression | GSE3982_BCELL_VS_CENT_MEMORY_CD4_TCELL_UP | 6.53e-05 | 198 | 56 | 5 | M5544 | |
| Coexpression | GSE33292_WT_VS_TCF1_KO_DN3_THYMOCYTE_UP | 6.69e-05 | 199 | 56 | 5 | M9420 | |
| Coexpression | GSE19401_PLN_VS_PEYERS_PATCH_FOLLICULAR_DC_DN | 6.69e-05 | 199 | 56 | 5 | M7667 | |
| Coexpression | GSE46606_UNSTIM_VS_CD40L_IL2_IL5_3DAY_STIMULATED_IRF4HIGH_SORTED_BCELL_DN | 6.69e-05 | 199 | 56 | 5 | M9832 | |
| Coexpression | FISCHER_G1_S_CELL_CYCLE | 6.85e-05 | 200 | 56 | 5 | M107 | |
| Coexpression | DANG_BOUND_BY_MYC | H2BC12L H2BC11 H2BC15 H2BC14 H2BC9 H2BC4 H2BC17 H2BC21 DIABLO SRP68 | 7.40e-05 | 1061 | 56 | 10 | M15774 |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C2_PLATELET_CELL | 1.66e-04 | 384 | 56 | 6 | M45735 | |
| Coexpression | MARSON_BOUND_BY_FOXP3_UNSTIMULATED | H2BC11 H2BC13 ERCC3 H2BC4 H2BC17 H2BC5 DNASE1L1 ZAP70 H2BC12 H2BC18 | 2.63e-04 | 1239 | 56 | 10 | M1743 |
| CoexpressionAtlas | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | 2.19e-10 | 32 | 56 | 6 | mendel_RNAseq_e17.5_Urothelium_ShhCreRFP_2500_K3 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | 6.34e-10 | 70 | 56 | 7 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MandArch_2500_K1 | 1.29e-09 | 125 | 56 | 8 | facebase_RNAseq_e9.5_MandArch_2500_K1 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | 3.71e-09 | 50 | 56 | 6 | gudmap_RNAseq_e11.5_Ureteric_bud_2500_K2 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | 1.00e-08 | 162 | 56 | 8 | gudmap_RNAseq_e15.5_Mesangium_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | 1.55e-08 | 110 | 56 | 7 | facebase_RNAseq_e8.5_ParaxMesoderm_2500_K0 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | 3.49e-08 | 72 | 56 | 6 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | 1.81e-07 | 157 | 56 | 7 | facebase_RNAseq_e8.5_FloorPlate_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500_K2 | 3.05e-07 | 54 | 56 | 5 | facebase_RNAseq_e9.5_FaceMes_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | 4.38e-07 | 58 | 56 | 5 | facebase_RNAseq_e8.5_NeuroEpith_hindBrain_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500_K1 | H2BC11 H2BC13 H2BC15 H2BC14 H2BC17 ADAMTS18 H2BC5 MFSD13A H2BC12 | 9.86e-07 | 402 | 56 | 9 | facebase_RNAseq_e10.5_OlfacPit_2500_K1 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | 4.96e-06 | 43 | 56 | 4 | gudmap_RNAseq_e15.5_Podocytes_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_2500_k-means-cluster#3 | 6.45e-06 | 268 | 56 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_2500_K3 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Endothelial_2500_K1 | H2BC11 RASIP1 NID2 RIN3 GPR12 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC3 MFSD13A DNASE1L1 H2BC12 | 9.60e-06 | 1377 | 56 | 14 | gudmap_RNAseq_e15.5_Endothelial_2500_K1 |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | 1.07e-05 | 52 | 56 | 4 | gudmap_RNAseq_e11.5_Ureteric_stalks_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500_k-means-cluster#1 | 2.55e-05 | 132 | 56 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500_K1 | |
| CoexpressionAtlas | kidney_adult_RenCorpuscGlomer_k-means-cluster#3_top-relative-expression-ranked_500 | 3.50e-05 | 141 | 56 | 5 | gudmap_kidney_adult_RenCorpuscGlomer_k3_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3 | 3.70e-05 | 71 | 56 | 4 | GSM605778_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000 | VPS9D1 H2BC11 SGMS2 H2BC15 H2BC14 H2BC4 H2BC21 H2BC3 TENM2 DNASE1L1 H2BC18 | 3.77e-05 | 968 | 56 | 11 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.41e-05 | 148 | 56 | 5 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K2 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th.TCRbko, TCRd+ Vg1.1+, Thymus, avg-3 | 5.63e-05 | 79 | 56 | 4 | GSM605784_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500_k-means-cluster#1 | 5.91e-05 | 80 | 56 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_FaceMes_2500 | DOCK5 H2BC11 RASIP1 SGMS2 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 6.81e-05 | 1226 | 56 | 12 | facebase_RNAseq_e9.5_FaceMes_2500 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_100 | 1.06e-04 | 93 | 56 | 4 | gudmap_kidney_adult_Podocyte_MafB_100 | |
| CoexpressionAtlas | ECTO amniotic fluid MSC_vs_ECTO blastocyst-Confounder_removed-fold2.0_adjp0.05 | 1.20e-04 | 183 | 56 | 5 | PCBC_ratio_ECTO amniotic fluid MSC_vs_ECTO blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K4 | 1.33e-04 | 431 | 56 | 7 | gudmap_RNAseq_e11.5_Ureteric_tips_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.36e-04 | 300 | 56 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_2500_K1 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500_K4 | DOCK5 H2BC11 DPP4 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 1.45e-04 | 1125 | 56 | 11 | facebase_RNAseq_e9.5_MaxArch_2500_K4 |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6+.Th.TCRbko, TCRd+ Vg1.1+ Vd6.3+, Thymus, avg-3 | 2.16e-04 | 327 | 56 | 6 | GSM605778_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_500 | 2.64e-04 | 482 | 56 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_500 | 2.77e-04 | 486 | 56 | 7 | Facebase_RNAseq_e9.5_Facial Mesenchyne_500 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_ParaxMesoderm_2500 | DOCK5 H2BC11 RASIP1 NID2 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 2.88e-04 | 1429 | 56 | 12 | facebase_RNAseq_e8.5_ParaxMesoderm_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 3.91e-04 | 236 | 56 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K1 | |
| CoexpressionAtlas | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K3 | H2BC11 SGMS2 H2BC13 H2BC15 H2BC14 H2BC17 ADAMTS18 H2BC5 H2BC3 MFSD13A H2BC12 | 4.03e-04 | 1266 | 56 | 11 | mendel_RNAseq_e12.5_Urothelium_ShhCreRFP_2500_K3 |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d6.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 4.43e-04 | 374 | 56 | 6 | GSM538389_500 | |
| CoexpressionAtlas | Myeloid Cells, Mo.6C+II-.BM, B220neg CD3neg CD115+ Ly-6C+, Bone marrow, avg-3 | 5.60e-04 | 391 | 56 | 6 | GSM854329_500 | |
| CoexpressionAtlas | B cells, B.Pl.AA4-.BM, CD138+ AA4.1- CD43+, Bone marrow, avg-2 | 5.83e-04 | 394 | 56 | 6 | GSM777030_500 | |
| CoexpressionAtlas | EB amniotic fluid MSC_vs_EB blastocyst-Confounder_removed-fold2.0_adjp0.05 | 6.04e-04 | 727 | 56 | 8 | PCBC_ratio_EB amniotic fluid MSC_vs_EB blastocyst_cfr-2X-p05 | |
| CoexpressionAtlas | dev gonad_e12.5_M_SertoliCell_Sox9_k-means-cluster#3_top-relative-expression-ranked_500 | 6.12e-04 | 147 | 56 | 4 | gudmap_dev gonad_e12.5_M_SertoliCell_Sox9_k3_500 | |
| CoexpressionAtlas | Stem Cells, SC.GMP.BM, Lineage- sca1- ckithi CD34+ FcgRhi, Bone marrow, avg-3 | 6.82e-04 | 406 | 56 | 6 | GSM791119_500 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 7.09e-04 | 409 | 56 | 6 | GSM399452_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 7.18e-04 | 410 | 56 | 6 | GSM538387_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_2500_k-means-cluster#4 | 7.83e-04 | 275 | 56 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_2500_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e9.5_MaxArch_2500 | DOCK5 H2BC11 DPP4 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC3 H2BC12 H2BC18 | 7.86e-04 | 1371 | 56 | 11 | facebase_RNAseq_e9.5_MaxArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000 | VPS9D1 H2BC15 H2BC14 H2BC4 H2BC21 H2BC3 TENM2 DNASE1L1 H2BC18 | 8.94e-04 | 967 | 56 | 9 | Facebase_RNAseq_e9.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000 | 9.76e-04 | 979 | 56 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_SertoliCell_Sox9_k-means-cluster#2_top-relative-expression-ranked_500 | 1.01e-03 | 168 | 56 | 4 | gudmap_dev gonad_e13.5_M_SertoliCell_Sox9_k2_500 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_CollectIng Duct_2500_K2 | 1.06e-03 | 609 | 56 | 7 | gudmap_RNAseq_e15.5_CollectIng Duct_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 | H2BC11 H2BC13 H2BC15 H2BC14 H2BC17 H2BC5 H2BC3 MFSD13A H2BC12 H2BC18 | 1.07e-03 | 1202 | 56 | 10 | facebase_RNAseq_e8.5_NeuroEpith_nonFloor_2500 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_OlfacPit_2500 | H2BC11 H2BC13 H2BC15 H2BC14 H2BC17 ADAMTS18 H2BC5 H2BC3 MFSD13A H2BC12 H2BC18 | 1.27e-03 | 1453 | 56 | 11 | facebase_RNAseq_e10.5_OlfacPit_2500 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_200 | 1.27e-03 | 179 | 56 | 4 | gudmap_kidney_adult_Podocyte_MafB_200 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.27e-03 | 629 | 56 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K1 | |
| CoexpressionAtlas | Stem Cells, SC.GMP.BM, Lineage- sca1- ckithi CD34+ FcgRhi, Bone marrow, avg-3 | 1.28e-03 | 81 | 56 | 3 | GSM791119_100 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg1+vd6-.Th, TCRd+ Vg1.1+, Thymus, avg-3 | 1.28e-03 | 81 | 56 | 3 | GSM605781_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_stage III -IV renal corpusc_emap-27945_k-means-cluster#3_top-relative-expression-ranked_200 | 1.39e-03 | 21 | 56 | 2 | gudmap_developingKidney_e15.5_stage III -IV renal corpusc_200_k3 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-09 | 174 | 57 | 7 | 021ebc6ec022b992d7b25333ba0b7416371e041b | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.57e-09 | 174 | 57 | 7 | c2fc78dd6c440737ded59676961e4c7b923084ce | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-09 | 195 | 57 | 7 | 294c74336fafc1bad237d851efb4a487475078eb | |
| ToppCell | facs-Marrow-B-cells-3m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.68e-09 | 195 | 57 | 7 | 5749ea833be84e262e3d0a4fe1a9a373f0ef545f | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 179 | 57 | 6 | b88791dd4e73bb8410ca090938a1a45b0bc16e69 | |
| ToppCell | facs-Marrow-B-cells-18m-Myeloid-granulocyte_monocyte_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-07 | 179 | 57 | 6 | c063028b82c68d929aef2421daade9dc189a6963 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 1.16e-07 | 180 | 57 | 6 | 1be264962fd4ed0bb59f9b8a6956c4239ca32e05 | |
| ToppCell | PBMC-Mild-Hematopoietic-Platelet-Platelet-plt_4|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.16e-07 | 180 | 57 | 6 | 5568063c2518fadb638e665635061ec10d00fb6a | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-07 | 193 | 57 | 6 | 9c2f58b4c89dc084a1a6e53952ea793e87a96660 | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.74e-07 | 193 | 57 | 6 | db881cc129b45031fd84d052768cef53508de196 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 1.91e-07 | 196 | 57 | 6 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | moderate-Epithelial-unknown_epithelial|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.92e-07 | 130 | 57 | 5 | a04057bd4f256d09eca06b8c1e8b41425bb4ef3f | |
| ToppCell | NS-moderate-d_16-33-Epithelial-unknown_epithelial|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.97e-07 | 137 | 57 | 5 | 03e124901a0e85b59b6882bbafab568b50907e8b | |
| ToppCell | moderate-Epithelial-unknown_epithelial|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.30e-07 | 138 | 57 | 5 | afefa8233c67aa744e939156bc538449bf6bd05b | |
| ToppCell | PCW_13-14-Hematologic_ErythroMegGranulo-Hem_ErythroMeg-im_megakaryocyte1_(20)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 1.81e-06 | 158 | 57 | 5 | 944c5fe625f965dd6153dbcbf5577f99ad343983 | |
| ToppCell | PND03-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.24e-06 | 165 | 57 | 5 | 26c750f10f6401752e2e63d91dc844c81b29d735 | |
| ToppCell | facs-SCAT-Fat-18m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-06 | 169 | 57 | 5 | 700a3a36c379872585204caa6a6cc269b036ae22 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic-Plasmacytoid_Dendritic_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.67e-06 | 171 | 57 | 5 | 39c8ae139e449217091e1481eb5e2aafb8f69a1c | |
| ToppCell | droplet-Lung-1m-Hematologic-Lymphocytic_NK_ILC-natural_killer_cell-proliferating_NK|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.83e-06 | 173 | 57 | 5 | c399786aa25bdbe3394988db6955842b5b7e6b41 | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_NK|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-06 | 173 | 57 | 5 | 31784679190fbd95fc23d7c66008eb21b8c7cc5d | |
| ToppCell | -IPF_02|World / lung cells shred on cell class, cell subclass, sample id | 2.91e-06 | 174 | 57 | 5 | ba50cc04fcdee1926d4af4787ac86555ae9632cc | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 3.52e-06 | 181 | 57 | 5 | c35ca98c474e31917e0a53c092397e0d8d18b37c | |
| ToppCell | COVID-19_Mild|World / Disease Group and Platelet Clusters | 3.62e-06 | 182 | 57 | 5 | 90c61e10c7860bfba6ccfe6f37671c8924637f7b | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.92e-06 | 185 | 57 | 5 | 0e0f043ad6d2a62cd47ce39911ad81feab4a4d7e | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.92e-06 | 185 | 57 | 5 | 709236097cbfc254796fcc69b5f5178b73dad9bd | |
| ToppCell | PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.92e-06 | 185 | 57 | 5 | af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28 | |
| ToppCell | droplet-Lung-1m-Hematologic-lymphocytic-Proliferating_T_cell-proliferating_T|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.92e-06 | 185 | 57 | 5 | 89b85ce8026dc80c1bd9f76dfe16401c173b7946 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.92e-06 | 185 | 57 | 5 | 698ff44fd2d9b3ad5cea45f4cff9bfc64c559b62 | |
| ToppCell | PBMC-Severe-Hematopoietic-Platelet-Platelet-plt_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.02e-06 | 186 | 57 | 5 | 981116561986f94e9cc3ee64fb37dab9a31d427a | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|World / disease group, cell group and cell class (v2) | 4.46e-06 | 190 | 57 | 5 | 7aaf82f0c235363afb95cf1fa51c2a5b070b1af8 | |
| ToppCell | Control-Lymphoid-Proliferating_CD4_T_cells|Control / Condition, Lineage and Cell class | 4.82e-06 | 193 | 57 | 5 | 33d409d6ed1c606337248587ad997ac5f67f081d | |
| ToppCell | COVID-19_Mild-PLT_4|World / Disease Group and Platelet Clusters | 4.82e-06 | 193 | 57 | 5 | 98a52523aa1efd5d14a2878ed106828a80a33aa2 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.07e-06 | 195 | 57 | 5 | 027075e9c62b5754a014a9d1393e1b0f5ae42e41 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 5.07e-06 | 195 | 57 | 5 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | Parenchymal-NucSeq-Immune_Myeloid-Myeloid-Megakaryocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.07e-06 | 195 | 57 | 5 | 1bcc0c8b1281396b1433ce5a2ec8681de47ce9ad | |
| ToppCell | NS-critical-d_07-13-Lymphoid-NKT-proliferating|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 5.73e-06 | 200 | 57 | 5 | 7f5cd05bb1b9a83baceddb7d7f0a9ec9781cda29 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-05 | 142 | 57 | 4 | 7b6678a73d04feac12bbc909f2df478215511de0 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-C_(Myofibroblast)-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 3.30e-05 | 142 | 57 | 4 | 347f5832a86f4e41752e36e3e737df7ca6f79e90 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.78e-05 | 147 | 57 | 4 | 22d71cf92b957e5a8aa63b13157626d013d6752b | |
| ToppCell | PND14-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_T-CD4_T-CD4_T_prolif|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.09e-05 | 150 | 57 | 4 | 7bc61eb4b8c4a1909f4b7bcd1c6a88ef46102669 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.76e-05 | 156 | 57 | 4 | 7569cab30caafcb273e8ef0b73c9e1bf87076984 | |
| ToppCell | wk_15-18-Hematologic-Meg-ery-Platelet|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 5.25e-05 | 160 | 57 | 4 | 768f3cefc3ad4cda229e598cce8bde574cf64bb2 | |
| ToppCell | PND03-Immune-Immune_Myeloid-DC-cDC1|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.38e-05 | 161 | 57 | 4 | 0e2b54a63781397f6b99eb0e201fbb820cbd7cc6 | |
| ToppCell | 390C-Myeloid-Dendritic-cDC_proliferating_2|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 5.51e-05 | 162 | 57 | 4 | a957c7e347189b72fbd47db3075bb5e879a21c67 | |
| ToppCell | Control-Lymphocyte-B-Plasmablast|Control / Disease, Lineage and Cell Type | 5.51e-05 | 162 | 57 | 4 | 67b32c40cc180c5ebbfd901a417b5be469500110 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.35e-05 | 168 | 57 | 4 | 6521bead9789d626b86cbd08692c621c5a5aef33 | |
| ToppCell | PND07-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-ILC-ILC_G2M|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 6.35e-05 | 168 | 57 | 4 | a7eb28e15b591997f1aee09501cb20ae18beca08 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-basal_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.50e-05 | 169 | 57 | 4 | c3ee781735a9288ce1822b230d39bb91c1415589 | |
| ToppCell | 390C-Lymphocytic-NK_cells-Proliferating_NK_cell|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.65e-05 | 170 | 57 | 4 | 5319f73cff64f2bb67472c7156ee1d0f006c6fc0 | |
| ToppCell | 10x5'-Lung-Lymphocytic_B_plasma|Lung / Manually curated celltypes from each tissue | 6.96e-05 | 172 | 57 | 4 | 8156fb6de66a4c92ade703b71c2e9187291e50ef | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-Double_negative_thymocyte,_DN3_(Cd8-,_Cd4-),_some_express_pre_TCR_alpha|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 174 | 57 | 4 | a9f34d1237f335d27c5560ff514368f4709f9144 | |
| ToppCell | facs-SCAT-Fat-24m-Lymphocytic-T_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.27e-05 | 174 | 57 | 4 | 6ca9433d398aa3b48ecdc522dd545119e7c77dd4 | |
| ToppCell | 390C-Lymphocytic-CD4_T-cell-CD4+_Effector_T_cell-1|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 7.44e-05 | 175 | 57 | 4 | 6374ab186d7ccf7f6dfb858267edba8962789e15 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-dendritic_type_2|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.60e-05 | 176 | 57 | 4 | 7b5e50eb144bf43ca0cf354a466eb58b976a79f1 | |
| ToppCell | droplet-Thymus-nan-21m-Lymphocytic-DN3_thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.60e-05 | 176 | 57 | 4 | d43d9e86c4d4fa1e88fbf2b899ac7143717aac90 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.77e-05 | 177 | 57 | 4 | a4c001a8e44142babf9f24dfe6f7b73a70b11b16 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_goblet_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.77e-05 | 177 | 57 | 4 | 363e07b0f347f3716d530a28ead854b98e27d37c | |
| ToppCell | tumor_Lung-B_lymphocytes-GC_B_cells_in_the_DZ|tumor_Lung / Location, Cell class and cell subclass | 7.94e-05 | 178 | 57 | 4 | c57f92e57548638f1627dc7d313137f406dbecff | |
| ToppCell | 21-Trachea-Immune-Hematopoietic,_Natural_Killer_Cell|Trachea / Age, Tissue, Lineage and Cell class | 7.94e-05 | 178 | 57 | 4 | d2e1f6b7933b7da2682393e5ff5e03cdd8f64761 | |
| ToppCell | TCGA-Head_and_Esophagus-Primary_Tumor-Esophageal_Carcinoma-Esophagus_Squamous_Cell_Carcinoma-9|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 7.96e-05 | 65 | 57 | 3 | 5bcc7b96e0576245abef5f0f32cca5ec37a6780a | |
| ToppCell | droplet-Spleen-nan-21m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.12e-05 | 179 | 57 | 4 | dabecd283c1f0f71a66b804c99be8bd48ea36e35 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-05 | 181 | 57 | 4 | 9fce5eee75684a7ecac6996e26e9215bc95098b2 | |
| ToppCell | facs-Large_Intestine-Proximal-18m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.47e-05 | 181 | 57 | 4 | ad97e802e934738ddece675232a72308db2da256 | |
| ToppCell | wk_20-22-Hematologic-Meg-ery-Platelet|wk_20-22 / Celltypes from embryonic and fetal-stage human lung | 8.47e-05 | 181 | 57 | 4 | 724efbc200e8388829bc7d81830c2689a95fa838 | |
| ToppCell | droplet-Thymus-nan-24m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.66e-05 | 182 | 57 | 4 | 39f9b3eb22293cc27c6e175702c77d1eeb24fdc9 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-05 | 183 | 57 | 4 | bc24145855bf4d027a8058bf92bc796c10f241bb | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-Proliferating_T|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-05 | 183 | 57 | 4 | 769a022fe8568ec49e66f792cc5777e713a7571c | |
| ToppCell | droplet-Lung-LUNG-1m-Lymphocytic-T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-05 | 183 | 57 | 4 | aac0695fafa59cabd920ee18b1139d3e00d898e8 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.84e-05 | 183 | 57 | 4 | 4c325ee6da070513097a11445ec95b0415ffd8a2 | |
| ToppCell | Parenchymal-10x3prime_v2-Immune_Lymphocytic-T-T_CD8-CD8_TRM|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.03e-05 | 184 | 57 | 4 | 17ffa0e890960c00a3b5fa33d48caba66c61dbb0 | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma-Plasma_cells|GI_large-bowel / Manually curated celltypes from each tissue | 9.22e-05 | 185 | 57 | 4 | 2cad994207c4afc9d70f4c2d243ffbbcdbba693e | |
| ToppCell | 10x5'-GI_large-bowel-Lymphocytic_B_plasma|GI_large-bowel / Manually curated celltypes from each tissue | 9.22e-05 | 185 | 57 | 4 | 989583c487d8c121e3731faf68f863ba43a582e6 | |
| ToppCell | -IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 9.22e-05 | 185 | 57 | 4 | 10f7e5daf8e95dda9453212e84b64874f4e0d7ab | |
| ToppCell | 10x5'-lymph-node_spleen-Hematopoietic_progenitors-Progenitor_pre-Lymphocytic-T|lymph-node_spleen / Manually curated celltypes from each tissue | 9.41e-05 | 186 | 57 | 4 | 17eec1efad1f5e9ced1eb6bc9eb5dd7ded789c61 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 186 | 57 | 4 | 15ab6666748a641226e42e6ca6eeaf186a501c95 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.41e-05 | 186 | 57 | 4 | 4ed1b97e2552f3c4134f25665d7513498ffac16c | |
| ToppCell | TCGA-Breast-Primary_Tumor-Breast_Carcinoma-Infiltrating_Ductal_Carcinoma-6|TCGA-Breast / Sample_Type by Project: Shred V9 | 9.61e-05 | 187 | 57 | 4 | a96495803ba13fcfadd1d83b3cf5774f3fed0a20 | |
| ToppCell | mild_COVID-19-Platelet|World / disease group, cell group and cell class (v2) | 1.00e-04 | 189 | 57 | 4 | 038ec3c266b89416bb5b774ba522d916394961da | |
| ToppCell | B_cells-Plasmablasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 1.00e-04 | 189 | 57 | 4 | 87cb7b6ba9fd57100d68e6eaeecd1ac6ab22d1c6 | |
| ToppCell | Globus_pallidus-Neuronal|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.02e-04 | 190 | 57 | 4 | 416de85d8841dac883faa6f5339b2fb461a09e82 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_Prolif-D|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.06e-04 | 192 | 57 | 4 | 90d25b0b38f1cd7a98c76c1f9e38166da6d7a316 | |
| ToppCell | mild_COVID-19_(asymptomatic)-Platelet|mild_COVID-19_(asymptomatic) / disease group, cell group and cell class (v2) | 1.09e-04 | 193 | 57 | 4 | 9b97a7e9b5c1cc5db353070af0b9c5059714724b | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 194 | 57 | 4 | ad1aacff97beb76f4211942676e1d5e84087d44e | |
| ToppCell | facs-Marrow-B-cells-18m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.11e-04 | 194 | 57 | 4 | fdd59b1e036b2d6d8877e1a920a0e56a91a2a882 | |
| ToppCell | Biopsy_Control_(H.)-Immune-pDCs|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 1.13e-04 | 195 | 57 | 4 | 47d139215f0b51f5ea9b5fb09b1100e320e3f1e2 | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B_plasma-Plasmablasts|lymph-node_spleen / Manually curated celltypes from each tissue | 1.13e-04 | 195 | 57 | 4 | 1390728b9a514db534e8bc6dcf72cf51a1065780 | |
| ToppCell | facs-Thymus-nan-3m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 57 | 4 | 93c345e70d6c8ff5d12fd63d73228c1700b804a0 | |
| ToppCell | facs-Thymus-Thymus_Flowthrough-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.13e-04 | 195 | 57 | 4 | e9c7eb0b1a2d58f69b4e839665101948bd4527b8 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-04 | 196 | 57 | 4 | 96e5c6d155273e82ebafa180df8bb589c3e3e54e | |
| ToppCell | Caecum-T_cell-Tfh|T_cell / Region, Cell class and subclass | 1.15e-04 | 196 | 57 | 4 | fe2ee5788028e6b671674f0cc50e2b6379f50976 | |
| ToppCell | Bronchial-NucSeq-Stromal-Mesofibroblastic-Mesothelia|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.15e-04 | 196 | 57 | 4 | ce13af36fc2932e8125013041742593ff3d07e86 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Kif5b_(Kif5b)-|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.17e-04 | 74 | 57 | 3 | ebd6571675c446406c0e421537b0a4d38c9d8f10 | |
| ToppCell | Globus_pallidus-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Kif5b_(Kif5b)|Globus_pallidus / BrainAtlas - Mouse McCarroll V32 | 1.17e-04 | 74 | 57 | 3 | 96bee94904be2d022a6228d4c22b28ea34060407 | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.17e-04 | 197 | 57 | 4 | 0d38d126b1e653398426255e95449f1150eac1b0 | |
| ToppCell | Mild_COVID-19-T/NK-proliferating_T/NK|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 1.17e-04 | 197 | 57 | 4 | 5fd52fba2cb6fa67377f873da2ff6ce9c83b0591 | |
| ToppCell | Parenchyma_Control_(B.)-Immune-TX-Plasma_cells|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.17e-04 | 197 | 57 | 4 | 7ffb373d5b72c67e4816f14ea9a7a2024dc7a93a | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-04 | 197 | 57 | 4 | 2e76e9ebd8702bfeefd396cbf5114eee0f24c19b | |
| ToppCell | Lung_Parenchyma-Control-Lymphocyte-B-Plasmablast-Plasmablast|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-04 | 197 | 57 | 4 | 207fce47e547fafbaf64a22efe3488e74bf19bed | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T-T/NK_proliferative|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-04 | 197 | 57 | 4 | 434a5686a103bb766e0d80038413f0e12ea3981a | |
| ToppCell | BAL-Mild-Lymphocyte-T/NK-Other_T|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.17e-04 | 197 | 57 | 4 | 6bddfa199ca812d9e518eaa02c3d4fb67e9f5b16 | |
| Computational | Genes in the cancer module 90. | 7.21e-10 | 17 | 30 | 5 | MODULE_90 | |
| Computational | Genes in the cancer module 189. | 3.88e-09 | 23 | 30 | 5 | MODULE_189 | |
| Computational | Genes in the cancer module 127. | 7.53e-09 | 26 | 30 | 5 | MODULE_127 | |
| Computational | Genes in the cancer module 89. | 4.84e-08 | 14 | 30 | 4 | MODULE_89 | |
| Computational | Genes in the cancer module 203. | 8.77e-08 | 16 | 30 | 4 | MODULE_203 | |
| Computational | Chromatin and nucleosomes. | 1.47e-07 | 18 | 30 | 4 | MODULE_552 | |
| Computational | Genes in the cancer module 534. | 1.47e-07 | 18 | 30 | 4 | MODULE_534 | |
| Computational | Genes in the cancer module 168. | 3.48e-07 | 22 | 30 | 4 | MODULE_168 | |
| Computational | Genes in the cancer module 222. | 3.48e-07 | 22 | 30 | 4 | MODULE_222 | |
| Computational | Chromatin. | 9.63e-07 | 28 | 30 | 4 | MODULE_421 | |
| Computational | rRNA processing and DNA repair. | 1.12e-03 | 18 | 30 | 2 | MODULE_392 | |
| Drug | Methylmethacrylate | 3.96e-14 | 39 | 55 | 8 | ctd:D020366 | |
| Drug | Berberine | 1.27e-09 | 202 | 55 | 9 | ctd:D001599 | |
| Drug | Anisomycin [22862-76-6]; Up 200; 15uM; MCF7; HT_HG-U133A | 2.39e-06 | 160 | 55 | 6 | 5364_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; HL60; HT_HG-U133A | 3.51e-06 | 171 | 55 | 6 | 2723_UP | |
| Drug | Cycloheximide [66-81-9]; Up 200; 14.2uM; MCF7; HT_HG-U133A | 4.43e-06 | 178 | 55 | 6 | 6220_UP | |
| Drug | LY 294002; Up 200; 10uM; HL60; HT_HG-U133A | 5.36e-06 | 184 | 55 | 6 | 2696_UP | |
| Drug | OTX015 | 7.31e-06 | 16 | 55 | 3 | ctd:C000605331 | |
| Drug | MgCl2 | 2.21e-05 | 354 | 55 | 7 | CID000024584 | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 5.03e-05 | 166 | 55 | 5 | 3290_UP | |
| Drug | Emetine dihydrochloride [316-42-7]; Up 200; 7.2uM; MCF7; HT_HG-U133A | 5.32e-05 | 168 | 55 | 5 | 2801_UP | |
| Drug | Cephaeline dihydrochloride heptahydrate [6487-30-5]; Up 200; 6uM; MCF7; HT_HG-U133A | 5.79e-05 | 171 | 55 | 5 | 5247_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A_EA | 7.98e-05 | 183 | 55 | 5 | 1074_UP | |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | 8.40e-05 | 185 | 55 | 5 | 6945_UP | |
| Drug | ICI 182,780; Up 200; 1uM; MCF7; HT_HG-U133A_EA | 8.83e-05 | 187 | 55 | 5 | 1043_UP | |
| Drug | LY 294002; Up 200; 10uM; PC3; HT_HG-U133A | 9.76e-05 | 191 | 55 | 5 | 4451_UP | |
| Drug | Vincristine | H2BC12L DPP4 TUBB3 H2BC4 H2BC21 ABCA5 DIABLO H2BC5 H2BC3 TENM2 H2BC12 | 1.02e-04 | 1182 | 55 | 11 | ctd:D014750 |
| Drug | manganese | 1.07e-04 | 791 | 55 | 9 | CID000023930 | |
| Drug | aspirin, USP; Up 200; 100uM; MCF7; HT_HG-U133A | 1.08e-04 | 195 | 55 | 5 | 5564_UP | |
| Drug | 3-alpha-Hydroxy-5-beta-androstan-17-one [53-42-9]; Down 200; 13.8uM; PC3; HT_HG-U133A | 1.10e-04 | 196 | 55 | 5 | 3742_DN | |
| Drug | Sparteine (-) [90-39-1]; Up 200; 17uM; MCF7; HT_HG-U133A | 1.13e-04 | 197 | 55 | 5 | 4391_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Down 200; 12.2uM; HL60; HT_HG-U133A | 1.16e-04 | 198 | 55 | 5 | 2969_DN | |
| Drug | p-dimethylaminocinnamaldehyde | 1.19e-04 | 7 | 55 | 2 | CID000092224 | |
| Disease | Inguinal hernia | 1.18e-06 | 287 | 56 | 7 | HP_0000023 | |
| Disease | stromal cell-derived factor 1 measurement | 7.38e-05 | 7 | 56 | 2 | EFO_0020756 | |
| Disease | white matter microstructure measurement | 9.54e-05 | 390 | 56 | 6 | EFO_0005674 | |
| Disease | melanocyte protein PMEL measurement | 9.83e-05 | 8 | 56 | 2 | EFO_0801792 | |
| Disease | Malignant neoplasm of breast | 1.76e-04 | 1074 | 56 | 9 | C0006142 | |
| Disease | serum iron measurement | 5.93e-04 | 86 | 56 | 3 | EFO_0006332 | |
| Disease | brain measurement, neuroimaging measurement | 6.01e-04 | 550 | 56 | 6 | EFO_0004346, EFO_0004464 | |
| Disease | Strabismus | 1.39e-03 | 29 | 56 | 2 | HP_0000486 | |
| Disease | ferritin measurement | 1.52e-03 | 119 | 56 | 3 | EFO_0004459 | |
| Disease | forced expiratory volume, response to bronchodilator | 1.55e-03 | 445 | 56 | 5 | EFO_0004314, GO_0097366 | |
| Disease | eyelid sagging measurement | 1.69e-03 | 32 | 56 | 2 | EFO_0009360 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| IISNYYLYHLNVTET | 986 | Q8WWZ7 | |
| INSHITLELYTSYLY | 21 | Q9BXU8 | |
| SLYYALTYHSERTVT | 141 | P47775 | |
| TEYTKAVYTLTSLYR | 101 | Q9NR28 | |
| ESYSVYVYKVLKQVH | 36 | P57053 | |
| SSYLAVRSLSQKYYL | 786 | Q8TE60 | |
| QQSVYYLTKTLYSTL | 701 | Q5U651 | |
| YKVLLTYDTHVNKTY | 391 | P25092 | |
| ESYSIYVYKVLKQVH | 36 | Q16778 | |
| ESYSVYVYKVLKQVH | 36 | Q5QNW6 | |
| ESYSIYVYKVLKQVH | 36 | P06899 | |
| ESYSVYVYKVLKQVH | 36 | Q99877 | |
| AATPSVYLLYKTSHY | 211 | Q96DC9 | |
| AIISIYYYHIAKTLI | 226 | P28336 | |
| ESYSVYVYKVLKQVH | 36 | Q99879 | |
| ESYSVYVYKVLKQVH | 36 | P58876 | |
| ESYSVYVYKVLKQVH | 36 | Q93079 | |
| ESYSVYVYKVLKQVH | 36 | O60814 | |
| SKIYTTHISYLEIYN | 136 | Q6ZMV9 | |
| KTYTLTDYLKNTYRL | 41 | P27487 | |
| KIASATHNIYAYRIY | 211 | Q9P2X3 | |
| SYYEKLHTYFPVSSL | 331 | P16144 | |
| VTLEDIYESTTHYYL | 81 | Q96NX5 | |
| LVSTYKNYYSLVLDS | 396 | Q9Y5I2 | |
| YKELYHYSDSTVTST | 666 | Q14112 | |
| ESYSIYVYKVLKQVH | 36 | P33778 | |
| ESYSVYVYKVLKQVH | 36 | P62807 | |
| ESYSIYVYKVLKQVH | 36 | Q8N257 | |
| YFYRSHKTQVLSSYV | 101 | P49184 | |
| LETYIYKHFSATLAY | 716 | Q9H7D0 | |
| YRTHIYIQTDITGYK | 466 | Q96JB2 | |
| ESYSVYVYKVLKQVH | 36 | Q99880 | |
| ESYSIYVYKVLKQVH | 36 | P23527 | |
| YSHTYETLYILSKTN | 31 | Q8TF61 | |
| TRQLHEKTSQLSYYY | 391 | O95260 | |
| KQKYTDHLQSYVIYS | 756 | Q9NV70 | |
| THVHEYKLTAYSLYA | 111 | P19447 | |
| YVLRFYNTYSLVHSK | 361 | B5MCN3 | |
| YNTYSLVHSKRISYT | 366 | B5MCN3 | |
| TTILHNVFLLYYVDT | 26 | Q14CX5 | |
| YSISHYYNTSEKITS | 381 | Q8TE73 | |
| HYYRIVKSTLLLYQS | 51 | Q93100 | |
| YLTTTYGALEHIKSY | 826 | Q8TB24 | |
| YYSQESKVLYLLLTS | 141 | Q8ND04 | |
| IHQYTVSLVTGEYLY | 1601 | Q9NT68 | |
| ILHDNVILKSIYYYT | 471 | Q99457 | |
| EHYTIDVIIAYYITT | 271 | Q8NHU3 | |
| LQYLHSYLTYIKLST | 376 | Q9UHB9 | |
| SLIYGKTVYHYLISQ | 201 | P43403 | |
| TLATYLSKNYSYVIH | 186 | Q6FHJ7 | |
| TIIVYYYRKHTKINS | 51 | Q5MJ10 | |
| KSIITYVVSFYHYFS | 271 | Q9H254 | |
| RISVYYNEASSHKYV | 46 | Q13509 | |
| YTEYLRSIHYISQVL | 36 | Q9Y2B5 | |
| YVIRLYHEATTDTYK | 166 | Q9BUB7 | |
| SLHTVRYYSKVTPSY | 361 | Q9NX45 | |
| STAKKVLLSYYTQYS | 446 | Q9NR99 | |
| EDSTYYYLLHKSIQE | 1506 | Q8NEV4 | |
| LIRYQQHKIYTYTGS | 86 | Q6PIF6 |